tiprankstipranks
TC Biopharm Announces Special Stock Dividend and Temporary Trading Halt
Company Announcements

TC Biopharm Announces Special Stock Dividend and Temporary Trading Halt

Story Highlights

Don't Miss Our New Year's Offers:

The latest update is out from TC Biopharm (Holdings) Plc Sponsored ADR ( (TCBP) ).

TC Biopharm has announced the approval and distribution of a special stock dividend for its shareholders, consisting of 0.25 American Depositary Shares per 1 ADS held, to be recorded on January 2, 2025. As a result, trading of its ADSs on the Nasdaq will be temporarily halted from January 2 to January 8, 2025, to facilitate the orderly distribution and adjust the price to reflect the dividend’s dilution effect.

More about TC Biopharm (Holdings) Plc Sponsored ADR

TC Biopharm (Holdings) PLC operates within the biopharmaceutical industry, focusing on developing novel immunotherapy products that target cancer and infectious diseases. The company is known for its work with advanced cell therapies and aims to provide innovative treatments that address unmet medical needs.

YTD Price Performance: -98.08%

Average Trading Volume: 1,757,259

Technical Sentiment Consensus Rating: Buy

Current Market Cap: $300.7K

See more data about TCBP stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyTC Biopharm advances negotiations with acquisition candidates
TipRanks Auto-Generated NewsdeskTC BioPharm Approves Key Resolutions to Enhance Strategic Flexibility
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App